Monte Rosa Therapeutics, Inc. GLUE Gain (loss) on disposal of assets
Gain (loss) on disposal of assets at other companies
Other financials
Where this comes from
Reported directly by Monte Rosa Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monte Rosa Therapeutics, Inc.'s gain (loss) on disposal of assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monte Rosa Therapeutics, Inc.'s gain (loss) on disposal of assets?
- Monte Rosa Therapeutics, Inc. (GLUE) reported gain (loss) on disposal of assets of $0 in Q1 2026.
- How has Monte Rosa Therapeutics, Inc.'s gain (loss) on disposal of assets changed year-over-year?
- Monte Rosa Therapeutics, Inc.'s gain (loss) on disposal of assets decreased by 100.0% year-over-year, from $59K to $0.
- What does gain (loss) on disposal of assets mean?
- Gains or losses recognized on the disposal of businesses, property, equipment, investments, or other assets at prices above or below their carrying value.